Sec Form 4 Filing - Clarus IV-A, L.P. @ Galera Therapeutics, Inc. - 2019-11-12

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Clarus IV-A, L.P. 2. Issuer Name and Ticker or Trading Symbol Galera Therapeutics, Inc. [ GRTX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O CLARUS VENTURES, 101 MAIN STREET, SUITE 1210 3. Date of Earliest Transaction (MM/DD/YY) 11/12/2019 (Street) CAMBRIDGE, MA02142 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 11/12/2019 C 461,769 A 461,769 I See Footnotes ( 2 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 C 301,001 A 301,001 I See Footnotes ( 3 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 C 555,193 A 555,193 I See Footnotes ( 4 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 C 111,021 A 111,021 I See Footnotes ( 5 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 P 80,786 A $ 12 542,555 I See Footnotes ( 2 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 P 52,660 A $ 12 353,661 I See Footnotes ( 3 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 P 97,131 A $ 12 652,324 I See Footnotes ( 4 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Common Stock 11/12/2019 P 19,423 A $ 12 130,444 I See Footnotes ( 5 ) ( 6 ) ( 7 ) ( 8 ) ( 9 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series C Redeemable Convertible Preferred Stock ( 1 ) 11/12/2019 C 2,334,966 ( 1 ) ( 1 ) Common Stock 461,769 $ 0 0 I See Footnotes ( 2 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Series C Redeemable Convertible Preferred Stock ( 1 ) 11/12/2019 C 1,552,035 ( 1 ) ( 1 ) Common Stock 301,001 $ 0 0 I See Footnotes ( 3 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Series C Redeemable Convertible Preferred Stock ( 1 ) 11/12/2019 C 2,807,372 ( 1 ) ( 1 ) Common Stock 555,193 $ 0 0 I See Footnotes ( 4 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) Series C Redeemable Convertible Preferred Stock ( 1 ) 11/12/2019 C 561,385 ( 1 ) ( 1 ) Common Stock 111,021 $ 0 0 I See Footnotes ( 5 ) ( 6 ) ( 7 ) ( 8 ) ( 9 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Clarus IV-A, L.P. C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE, MA02142 X Clarus IV-B, L.P. C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE, MA02142 X Clarus IV-C, L.P. C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE, MA02142 X Clarus IV-D, L.P. C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE, MA02142 X Clarus IV GP L.P. C/O CLARUS VENTURES 101 MAIN STREET, SUITE 1210 CAMBRIDGE, MA02142 X Signatures CLARUS IV-A, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner By: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer 11/14/2019 Signature of Reporting Person Date CLARUS IV-B, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner By: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer 11/14/2019 Signature of Reporting Person Date CLARUS IV-C, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner By: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer 11/14/2019 Signature of Reporting Person Date CLARUS IV-D, L.P. By: Clarus IV GP, L.P., its general partner By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner By: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer 11/14/2019 Signature of Reporting Person Date CLARUS IV GP, L.P. By: Blackstone Clarus GP L.P., its general partner By: Blackstone Clarus GP L.L.C., its general partner By: /s/ John G. Finley Name: John G. Finley Title: Chief Legal Officer 11/14/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )These shares of the Issuer's Series C redeemable convertible preferred stock ("Redeemable Convertible Preferred Stock") are convertible into shares of the Issuer's common stock ("Common Stock") on a 0.197763-for-one basis at the holder's election and have no expiration date. The Redeemable Convertible Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering. ( 2 )These securities are held directly by Clarus IV-A, L.P. ( 3 )These securities are held directly by Clarus IV-B, L.P. ( 4 )These securities are held directly by Clarus IV-C, L.P. ( 5 )These securities are held directly by Clarus IV-D, L.P. (collectively, with Clarus IV-A, L.P., Clarus IV-B, L.P. and Clarus IV-C, L.P., the "Clarus Funds"). ( 6 )The general partner of each of the Clarus Funds is Clarus IV GP, L.P. The general partner of Clarus IV GP, L.P. is Blackstone Clarus GP L.P. The general partner of Blackstone Clarus GP L.P. is Blackstone Clarus GP L.L.C. The sole member of Blackstone Clarus GP L.L.C. is Blackstone Holdings II L.P. The general partner of Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Class C common stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman. ( 7 )Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 4. ( 8 )Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person. ( 9 )Each of such Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the Clarus Funds to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.

Remarks: Due to the number of shares of Common Stock outstanding after the closing of the Issuer's initial public offering on November 12, 2019, the Reporting Persons are no longer 10% beneficial owners.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.